This May Still Be an Early Copper Window
September 8, 2026 Bonus Content: Rheinmetall and BAE Systems Face a Peace-Talk Time Bomb A...
Daily Trader Insights
UK Gilts Near 6%: The Bond Market Is Writing the Budget
30-year gilt yields at a 28-year high have already consumed roughly half of Healey's fiscal room, and the OBR has…
Anthropic’s $2 Trillion Question Lands at the Worst Possible Moment
With a mid-October IPO window closing in on election week, the gap between private ambition and public-market reality is about…
Citi Moved the First Fed Cut to 2027. Watch Positioning
September 7, 2026 When a historically dovish house capitulates on easing, crowded trades on the...
Forget SpaceX, This Is Elon’s Next Breakthrough
September 7, 2026 Bonus Content: South Korea Already Told You What Tuesday’s China Trade Numbers...
Palantir’s Revenue Nearly Doubled. Now the Price Has to Catch Up.
A 93% revenue surge and a PwC deal cement Palantir’s commercial AI position, but a forward multiple above 110x still…
Copper Near $6.60 With Three Supply Crises at Once
Congo's concentrate export ban, Chile down 9.4%, and TC/RCs at zero keep the squeeze tight for FCX and SCCO.
Small Caps Rose Friday. The Market That Feared Rate Hikes Is Up 20% This Year.
September 6, 2026 Friday’s split session, Russell 2000 green while the S&P 500, Dow, and...
It’s Not Oil or Solar
September 6, 2026 Bonus Content: Fastenal’s best sales month in 4 years vs. ISM’s warning...
Moderna Doubled in a Day. What Happens Now Is the Real Question.
A melanoma Phase 3 win and an FDA-approved flu vaccine give Moderna its first credible platform since COVID. The stock…